Central serous chorioretinopathy associated with latanoprost use

dc.contributor.authorTufan, Hasan Ali
dc.contributor.authorGencer, Baran
dc.date.accessioned2025-01-27T19:04:18Z
dc.date.available2025-01-27T19:04:18Z
dc.date.issued2013
dc.departmentÇanakkale Onsekiz Mart Üniversitesi
dc.description.abstractA 55 years old man presented to our clinic with a 3 month history of blurred vision and micropsia in his left eye. He was previously diagnosed with unilateral glaucoma and treatment was initiated with topical latanoprost 0.005% and brimonidine tartrate/timolol maleate 0.2%/0.5% combination for the left eye in another clinic. The symptoms occurred one month after the initiation of glaucoma treatment. Fundus examination, optical coherence tomography and fluorescein angiography revealed a juxtafoveal neurosensory detachment which was coherent with central serous chorioretinopathy (CSC). After the cessation of latanoprost treatment, his clinical status improved and almost complete resolution of neurosensory detachment was observed spontaneously. The use of topical latanoprost may lead to CSC. Clinicians should consider this complication especially in patients presented with decreased visual acuity while using latonoprost.
dc.identifier.endpage141
dc.identifier.issn1300-1256
dc.identifier.issue2
dc.identifier.scopus2-s2.0-84878560834
dc.identifier.scopusqualityQ4
dc.identifier.startpage139
dc.identifier.trdizinid150085
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/150085
dc.identifier.urihttps://hdl.handle.net/20.500.12428/13898
dc.identifier.volume21
dc.indekslendigikaynakScopus
dc.indekslendigikaynakTR-Dizin
dc.language.isoen
dc.relation.ispartofRetina-Vitreus
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_Scopus_20250125
dc.subjectCentral serous chorioretinopathy; Glaucoma; Latanoprost
dc.titleCentral serous chorioretinopathy associated with latanoprost use
dc.typeArticle

Dosyalar